EFFECT OF DIABETES ON LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

Abstract

The severity of lower urinary tract symptoms in patients with BPH and the likelihood of having diabetes are significantly associated. Within the limitations of an open label, observational study tamsulosin appears to reduce lower urinary tract symptoms similarly in patients with BPH with or without diabetes.

References

Page 1

	Year	Citations
The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic Hyperplasia Herbert Lepor, William O. Williford, Michael J. Barry, New England Journal of Medicine	1996	796
Benign Prostatic Hyperplasia Specific Health Status Measures in Clinical Research: How Much Change in the American Urological Association Symptom Index and the Benign Prostatic Hyperplasia Impact Index is Perceptible to Patients? Michael J. Barry, William O. Williford, Yuchiao Chang, The Journal of Urology	1995	505
Phase III Multicenter Placebo-Controlled Study of Tamsulosin in Benign Prostatic Hyperplasia Herbert Lepor Urology	1998	368
THE DEVELOPMENT OF BENIGN PROSTATIC HYPERPLASIA AMONG VOLUNTEERS IN THE NORMATIVE AGING STUDY Robert J. Glynn, Edward W. Campion, G R Bouchard, American Journal of Epidemiology	1985	325
Natural History of Prostatism: Relationship Among Symptoms, Prostate Volume and Peak Urinary Flow Rate Cynthia J. Girman, Steven J. Jacobsen, Harry A. Guess, The Journal of Urology	1995	233
Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. A meta-analysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group. Christopher R. Chapple, J J Wyndaele, J. Nørdling, PubMed	1996	219
Selective alpha 1-adrenoceptor antagonists in benign prostatic hyperplasia: rationale and clinical experience. Christopher R. Chapple PubMed	1996	129
TAMSULOSIN TREATMENT OF 19,365 PATIENTS WITH LOWER URINARY TRACT SYMPTOMS: DOES CO-MORBIDITY ALTER TOLERABILITY? Martin C. Michel, LUDWIG MEHLBURGER, HANS-ULRICH BRESSEL, The Journal of Urology	1998	109
Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners: 1-year results B. Lukacs, Alain Leplège, P Thibault, Urology General PractitionersUrology1-Year ResultsGynecologyBenign Prostatic Hyperplasia	1996	98
Risk factors for surgically treatedbenign prostatic hyperplasia in a prepaid health care plan Stephen Sidney, Charles P. Quesenberry, Marianne Sadler, Urology UrologyHealth PolicyOutcomes ResearchBenign Prostatic HyperplasiaUrogynecology	1991	87

Page 1